Arbutus Biopharma Ownership | Who Owns Arbutus Biopharma?


OverviewForecastRevenueFinancialsChart

Arbutus Biopharma Ownership Summary


Arbutus Biopharma is owned by 16.33% institutional investors, 21.80% insiders, and 61.87% retail investors. Morgan stanley is the largest institutional shareholder, holding 12.76% of ABUS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Arbutus Biopharma shares.

ABUS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArbutus Biopharma16.33%21.80%61.87%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley24.45M12.76%$111.01M
Whitefort capital management, lp13.34M6.97%$60.58M
Blackrock funding, inc. /de12.68M6.62%$57.56M
Blackrock11.55M6.58%$35.70M
Two seas capital lp10.99M5.74%$49.90M
Vanguard group8.99M4.69%$40.82M
Adage capital partners gp5.01M2.62%$22.77M
State street4.10M2.14%$18.61M
Geode capital management3.67M1.91%$16.65M
Adar1 capital management2.90M1.52%$13.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Whitefort capital management, lp13.34M17.90%$60.58M
Fourworld capital management1.02M7.32%$4.63M
Corbin capital partners682.49K3.64%$2.23M
Rangeley capital840.00K3.30%$3.81M
Foursixthree capital lp1.98M2.47%$8.98M
Adar1 capital management2.90M1.24%$13.18M
Two seas capital lp10.99M0.80%$49.90M
Ledgewood wealth advisors278.44K0.75%$1.26M
Western standard507.85K0.68%$2.31M
Blackbarn capital partners lp2.00M0.65%$9.08M

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp5.01M0.04%2.44M
Blackrock11.55M0.00%1.15M
Ubs group774.59K0.00%584.39K
Two seas capital lp10.99M0.80%547.94K
Western standard507.85K0.68%507.85K

Top Sellers

HolderShares% AssetsChange
Ubs asset management americas---1.07M
Goldman sachs group2.17M0.00%-866.35K
Blackbarn capital partners lp2.00M0.65%-603.52K
Saba capital management678.77K0.08%-581.36K
Foursixthree capital lp1.98M2.47%-578.39K

New Positions

HolderShares% AssetsChangeValue
Western standard507.85K0.68%507.85K$2.31M
Murchinson200.00K0.12%200.00K$908.00K
Arrowstreet capital, limited partnership159.12K0.00%159.12K$722.40K
Campbell & co investment adviser73.28K0.03%73.28K$332.71K
Y-intercept (hong kong)66.06K0.01%66.06K$299.89K

Sold Out

HolderChange
Federated hermes-3.00
Nelson, van denburg & campbell wealth management group-24.00
Opal wealth advisors-100.00
Central trust-100.00
Gamma investing-127.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202575-54.55%31,275,575-65.40%160.73%29-61.33%24-44.19%
Jun 30, 2025173-6.49%118,008,1585.57%611.79%796.76%43-18.87%
Mar 31, 20259-94.48%30,187,875-70.98%160.54%8-89.19%--100.00%
Dec 31, 20241615.23%103,747,4872.96%541.93%73-5.19%4441.94%
Sep 30, 202415312.50%100,767,7004.58%532.03%778.45%313.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.92M2.57%-
Vanguard Total Stock Mkt Idx Inv4.77M2.49%-105.70K
Morgan Stanley Insight A4.24M2.23%399.58K
Morgan Stanley Insight I4.10M2.14%-97.92K
Morgan Stanley Insight4.10M2.14%-97.92K
iShares Russell 2000 ETF3.63M1.89%-
MS INVF Global Insight Z2.50M1.31%-
Morgan Stanley Inception2.10M1.10%-23.88K
Morgan Stanley Inst Inception I2.10M1.10%-23.88K
EQ/Morgan Stanley Small Cap Growth K1.67M0.87%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 04, 2025HASTINGS DAVID C Chief Financial OfficerSell$72.83K
Feb 04, 2025Sims Karen Chief Medical OfficerSell$63.52K
Feb 04, 2025McElhaugh Michael J. Interim President & CEOSell$78.10K
Feb 04, 2025Naftzger J. Christopher General Counsel and CCOSell$37.21K
Aug 14, 2024MANCHESTER KEITH S-Sell$32.64K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q1-4
2024 Q3-1
2024 Q2--
2024 Q1-4

ABUS Ownership FAQ


Who Owns Arbutus Biopharma?

Arbutus Biopharma shareholders are primarily institutional investors at 16.33%, followed by 21.80% insiders and 61.87% retail investors. The average institutional ownership in Arbutus Biopharma's industry, Biotech Stocks , is 45.24%, which Arbutus Biopharma falls below.

Who owns the most shares of Arbutus Biopharma?

Arbutus Biopharma’s largest shareholders are Morgan stanley (24.45M shares, 12.76%), Whitefort capital management, lp (13.34M shares, 6.97%), and Blackrock funding, inc. /de (12.68M shares, 6.62%). Together, they hold 26.35% of Arbutus Biopharma’s total shares outstanding.

Does Blackrock own Arbutus Biopharma?

Yes, BlackRock owns 6.58% of Arbutus Biopharma, totaling 11.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.7M$. In the last quarter, BlackRock increased its holdings by 1.15M shares, a 11.03% change.

Who is Arbutus Biopharma’s biggest shareholder by percentage of total assets invested?

Whitefort capital management, lp is Arbutus Biopharma’s biggest shareholder by percentage of total assets invested, with 17.90% of its assets in 13.34M Arbutus Biopharma shares, valued at 60.58M$.

Who is the top mutual fund holder of Arbutus Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Arbutus Biopharma shares, with 2.57% of its total shares outstanding invested in 4.92M Arbutus Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools